Results

Total Results: 2,080 records

Showing results for "drug".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_executive.pdf
    August 01, 2014 - Non-ACS conditions can include noncoronary causes (e.g., sepsis, congestive heart failure, myocarditis, drug … Food and Drug Administration approved the measurement of troponin T in dialysis patients for the express … Food and Drug Administration approved the measurement of troponin T in dialysis patients for the express … Regarding CKD patients without suspected ACS, our findings support the current Food and Drug Administration
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
    November 01, 2019 - diagnosing C. diff. 18) Does the recommendation specify patient characteristics (such as coincident drug … trigger the thought. 18) Does the recommendation specify patient characteristics (such as coincident drug … Recommendations 18) Does the recommendation specify patient characteristics (such as coincident drug
  3. effectivehealthcare.ahrq.gov/products/health-data-mapping/protocol
    December 03, 2019 - Food and Drug Administration [FDA]), and relevant professional societies (e.g. the American Health Information
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol-2014.pdf
    January 01, 2014 - Some 32 percent of the costs were attributed to gouty arthritis attacks, and drug expenditures accounted
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
    March 17, 2020 - Food and Drug Administration [FDA]), and relevant professional societies (e.g. the American Health Information
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pain-chronic_research-protocol.pdf
    July 28, 2010 - Evidence-based Practice Center Technical Brief Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: July 28, 2010 1 Evidence-based Practice Center Technical Brief Protocol Project Title: Technical Brief - Multidisciplinary Pain Programs for Chronic Non-Cancer Pain I. Background an…
  7. effectivehealthcare.ahrq.gov/products/medical-evidence-communication/research-protocol
    July 31, 2012 - Negative (loss) frame: “With drug X, you have a 5% chance of dying” vs. … “With drug X, you have a 95% chance of surviving.”
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
    June 01, 2013 - We invited drug manufacturers to submit additional information through a scientific information packets … Manual searching and contacts with drug manufacturers via the scientific information packet requests
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-masks-prevention-covid-version-1.pdf
    December 01, 2021 - Infect Disord Drug Targets. 2014;14(2):110-6. doi: 10.2174/1871526514666141021112855. … Infect Disord Drug Targets. 2014;14(2):110-6. doi: 10.2174/1871526514666141021112855.
  10. effectivehealthcare.ahrq.gov/products/mental-health-substance-abuse/research
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
    March 05, 2015 - consider when making clinical recommendations about relative efficacy of hormonal vs. nonhormonal drug
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_disposition-comments.pdf
    May 29, 2013 - well as this group are at higher risk for DVT and also at higher risk for bleeding due to potential drug … antiplatelet therapy, renal failure, and bariatric surgery is clear to me since the risks of anticoagulant drug-based
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-evidence-communication_research-protocol.pdf
    July 31, 2012 - o Negative (loss) frame: “With drug X, you have a 5% chance of dying” vs. … “With drug X, you have a 95% chance of surviving.”
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/trauma-child-interventions_research-protocol.pdf
    March 26, 2012 - emotional abuse (11%), physical abuse (28%), sexual abuse (21%), battered mother (13%), household drug
  15. effectivehealthcare.ahrq.gov/products/antibiotics-respiratory-infection/research-protocol/
  16. effectivehealthcare.ahrq.gov/products/asthma-treatment/research-protocol
    January 27, 2011 - Food and Drug Administration Medical and Statistical Reviews and Authorized Medicines for the European
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/worker-health_research-protocol.pdf
    May 26, 2015 - , quality of life, stress or distress o KQ 2b: Intermediate outcomes: Tobacco, alcohol or other drug
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_executive.pdf
    July 01, 2012 - Prostate-specific antigen (PSA) was approved by the US Food and Drug Administration in 1986 for monitoring
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
    February 01, 2012 - mortality, secondary malignancies), moderate-strength evidence suggests that extended periods of drug-free
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/behavior-change_research.pdf
    August 01, 2015 - Reviews of behavior change interventions often face a greater data extraction burden than reviews of drug … At a very practical level this occurs, for example, when a drug can be described by a limited set of … Unlike drug studies (but often similar to surgical or medical device interventions), the qualifications

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: